NCT00568594 - Safety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD) | Biotech Hunter

Enrollment

176

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

September 30, 2009

Conditions

Coronary Heart Disease

Interventions

DRUG

APL180

DRUG

Placebo

Trial Locations (11)

Novartis Investigator Site, Philadelphia

Novartis Investigator Site, Antwerp

Novartis Investigator Site, Birkeroed

Novartis Investigator Site, Jerusalem

Novartis Investigator Site, Tel Aviv

Novartis Investigator Site, Tzrifin

Novartis Investigator Site, Groningen

Novartis Investigator Site, Bloemfontein

Novartis Investigator Site, George

Novartis Investigator Site, Port Elizabeth

Novartis Investigator Site, Harrow